GlassScriptPhysician profile
Delia Delgado
NPI 1578592051
$2,817.97
in general payments reported to CMS, 2019-2025
33 companies · $482 in 2025
The $482 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $105 · 2021: $666 · 2022: $397 · 2023: $717 · 2024: $267 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,452 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,452.35 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $415.95 | 2021-2025 | Slynd |
| Abbvie INC. | $388.23 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Myovant Sciences INC. | $227.31 | 2021-2022 | |
| Astellas Pharma US INC | $207.78 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $184.73 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $182.79 | 2019-2025 | Aptima, Acessa Provu System, Myosure Tissue Removal Device |
| Pfizer INC. | $143.45 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $128.94 | 2021-2025 | |
| Millicent US INC | $115.73 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Intuitive Surgical, INC. | $97.68 | 2022 | |
| Channel Medsystems, INC. | $90.34 | 2023-2025 | |
| Axonics, INC. | $66.83 | 2022 | |
| Coopersurgical, INC. | $62.58 | 2023-2025 | Mara Console, Advincula Delineator Uterine Manipulator, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $60.13 | 2019-2025 | |
| Therapeuticsmd, INC. | $51.67 | 2019-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $40.75 | 2019-2023 | Balcoltra |
| Vertical Pharmaceuticals, LLC | $37.96 | 2019-2020 | |
| Ascend Therapeutics US, LLC | $31.34 | 2023 | |
| Covidien LP | $27.93 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $26.78 | 2023 | Vivjoa |
| Exact Sciences Corporation | $24.98 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $23.86 | 2020 | |
| Renovia INC | $22.47 | 2021 | |
| Meditrina | $22.46 | 2025 | |
| Medtronic, INC. | $22.09 | 2023 | Truclear |
| Organon LLC | $18.88 | 2025 | Jada System |
| Merck Sharp & Dohme LLC | $18.59 | 2019 | |
| Optumhealth Care Solutions, LLC | $16.65 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Minerva Surgical, INC | $15.47 | 2021 | |
| Evofem Biosciences, INC. | $15.39 | 2021 | |
| Dysis Medical, INC. | $14.25 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.98 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Delia Delgado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.